29. 8. 2016

Experts in the spotlight – Krka’s symposium in Rome

2 min. read

Living is like reading a book. Each new page brings new discoveries.

The scientific part of the symposium was expertly moderated by professor Michal Vrablík from the Czech Republic

At Krka’s symposium Experts in the Spotlight with the subtitle “Turning a new page, opening new possibilities”, we have turned a new page in the treatment of cardiovascular diseases. The symposium was held on 27 August during The European Society of Cardiology Congress in Rome. Experts from 20 countries were discussing the challenges and benefits of joining together a cholesterol-lowering and a blood-pressure lowering treatment.

The initial address to symposium participants, about 250 top medical doctors and key opinion leaders, was delivered by Krka’s medical director Breda Barbič-Žagar. She presented our company Krka and our achievements relating to medicines for the treatment of cardiovascular diseases and gave a thorough description of the process starting with the initial idea and ending with an effective, safe and quality medicine. She stressed the importance of knowledge and innovation as the sources of success.

During the scientific part of the symposium, led by the renowned cardiologist professor Michal Vrablik from the Czech Republic, the speakers presented new treatment options for cardiovascular diseases. In his introductory presentation professor Gianfranco Parati from Italy pointed at the significance of concomitant treatment for the two main cardiovascular disease risk factors, which are high cholesterol and high blood pressure. Professor Krzysztof J. Filipiak from Poland highlighted the importance of treatment adherence. He said that an optimal clinical effect of treatment can never be achieved if the patient does not take the prescribed medicines regularly. The last symposium speaker was professor Mišo Šabovič from Slovenia. He gave a presentation about the advantages of using fixed-dose combinations, stressing that they reduce the risk of developing cardiovascular disease and significantly improve the adherence of patients to their medication.

The symposium ended with a lively discussion during which the participants exchanged their experience and answered questions relating to concomitant treatment of high cholesterol and high blood pressure.